nodes	percent_of_prediction	percent_of_DWPC	metapath
Rizatriptan—Epistaxis—Fluorouracil—colon cancer	0.0029	0.0029	CcSEcCtD
Rizatriptan—Cerebrovascular accident—Capecitabine—colon cancer	0.00285	0.00285	CcSEcCtD
Rizatriptan—Osteoarthritis—Capecitabine—colon cancer	0.00279	0.00279	CcSEcCtD
Rizatriptan—Hypoaesthesia—Fluorouracil—colon cancer	0.00275	0.00275	CcSEcCtD
Rizatriptan—Pharyngitis—Fluorouracil—colon cancer	0.00274	0.00274	CcSEcCtD
Rizatriptan—Face oedema—Capecitabine—colon cancer	0.00269	0.00269	CcSEcCtD
Rizatriptan—Angiopathy—Vincristine—colon cancer	0.00268	0.00268	CcSEcCtD
Rizatriptan—Flushing—Irinotecan—colon cancer	0.00267	0.00267	CcSEcCtD
Rizatriptan—Irritability—Capecitabine—colon cancer	0.00266	0.00266	CcSEcCtD
Rizatriptan—Ataxia—Capecitabine—colon cancer	0.00262	0.00262	CcSEcCtD
Rizatriptan—Angiopathy—Irinotecan—colon cancer	0.00261	0.00261	CcSEcCtD
Rizatriptan—Dehydration—Capecitabine—colon cancer	0.00259	0.00259	CcSEcCtD
Rizatriptan—Mental disorder—Vincristine—colon cancer	0.00259	0.00259	CcSEcCtD
Rizatriptan—Chills—Irinotecan—colon cancer	0.00259	0.00259	CcSEcCtD
Rizatriptan—Urine output increased—Methotrexate—colon cancer	0.00259	0.00259	CcSEcCtD
Rizatriptan—Arrhythmia—Irinotecan—colon cancer	0.00257	0.00257	CcSEcCtD
Rizatriptan—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.00251	0.00251	CcSEcCtD
Rizatriptan—Nasopharyngitis—Capecitabine—colon cancer	0.00249	0.00249	CcSEcCtD
Rizatriptan—Flatulence—Irinotecan—colon cancer	0.00247	0.00247	CcSEcCtD
Rizatriptan—Gastritis—Capecitabine—colon cancer	0.00247	0.00247	CcSEcCtD
Rizatriptan—Arrhythmia—Fluorouracil—colon cancer	0.00247	0.00247	CcSEcCtD
Rizatriptan—Muscular weakness—Capecitabine—colon cancer	0.00246	0.00246	CcSEcCtD
Rizatriptan—Abdominal distension—Capecitabine—colon cancer	0.00243	0.00243	CcSEcCtD
Rizatriptan—Muscle spasms—Irinotecan—colon cancer	0.00241	0.00241	CcSEcCtD
Rizatriptan—Dysphagia—Capecitabine—colon cancer	0.00241	0.00241	CcSEcCtD
Rizatriptan—Erythema—Fluorouracil—colon cancer	0.0024	0.0024	CcSEcCtD
Rizatriptan—Agitation—Vincristine—colon cancer	0.00237	0.00237	CcSEcCtD
Rizatriptan—Polyuria—Methotrexate—colon cancer	0.00236	0.00236	CcSEcCtD
Rizatriptan—Photosensitivity—Methotrexate—colon cancer	0.00236	0.00236	CcSEcCtD
Rizatriptan—Angina pectoris—Capecitabine—colon cancer	0.00235	0.00235	CcSEcCtD
Rizatriptan—Vertigo—Vincristine—colon cancer	0.00231	0.00231	CcSEcCtD
Rizatriptan—Abdominal discomfort—Capecitabine—colon cancer	0.00231	0.00231	CcSEcCtD
Rizatriptan—Vision blurred—Fluorouracil—colon cancer	0.00226	0.00226	CcSEcCtD
Rizatriptan—Vertigo—Irinotecan—colon cancer	0.00225	0.00225	CcSEcCtD
Rizatriptan—Dysuria—Capecitabine—colon cancer	0.00225	0.00225	CcSEcCtD
Rizatriptan—Syncope—Irinotecan—colon cancer	0.00225	0.00225	CcSEcCtD
Rizatriptan—Upper respiratory tract infection—Capecitabine—colon cancer	0.00224	0.00224	CcSEcCtD
Rizatriptan—Convulsion—Vincristine—colon cancer	0.00223	0.00223	CcSEcCtD
Rizatriptan—Hypertension—Vincristine—colon cancer	0.00222	0.00222	CcSEcCtD
Rizatriptan—Loss of consciousness—Irinotecan—colon cancer	0.00221	0.00221	CcSEcCtD
Rizatriptan—Photosensitivity reaction—Capecitabine—colon cancer	0.0022	0.0022	CcSEcCtD
Rizatriptan—Myalgia—Vincristine—colon cancer	0.00219	0.00219	CcSEcCtD
Rizatriptan—Cough—Irinotecan—colon cancer	0.00219	0.00219	CcSEcCtD
Rizatriptan—Hypertension—Irinotecan—colon cancer	0.00217	0.00217	CcSEcCtD
Rizatriptan—Anaphylactoid reaction—Methotrexate—colon cancer	0.00214	0.00214	CcSEcCtD
Rizatriptan—Acute coronary syndrome—Capecitabine—colon cancer	0.00212	0.00212	CcSEcCtD
Rizatriptan—Cerebrovascular accident—Methotrexate—colon cancer	0.00212	0.00212	CcSEcCtD
Rizatriptan—Discomfort—Irinotecan—colon cancer	0.00211	0.00211	CcSEcCtD
Rizatriptan—Myocardial infarction—Capecitabine—colon cancer	0.00211	0.00211	CcSEcCtD
Rizatriptan—Oedema—Vincristine—colon cancer	0.0021	0.0021	CcSEcCtD
Rizatriptan—Anaphylactic shock—Vincristine—colon cancer	0.0021	0.0021	CcSEcCtD
Rizatriptan—Convulsion—Fluorouracil—colon cancer	0.00208	0.00208	CcSEcCtD
Rizatriptan—Osteoarthritis—Methotrexate—colon cancer	0.00208	0.00208	CcSEcCtD
Rizatriptan—Confusional state—Irinotecan—colon cancer	0.00206	0.00206	CcSEcCtD
Rizatriptan—Nervous system disorder—Vincristine—colon cancer	0.00206	0.00206	CcSEcCtD
Rizatriptan—Oedema—Irinotecan—colon cancer	0.00205	0.00205	CcSEcCtD
Rizatriptan—Anaphylactic shock—Irinotecan—colon cancer	0.00205	0.00205	CcSEcCtD
Rizatriptan—Chest pain—Fluorouracil—colon cancer	0.00205	0.00205	CcSEcCtD
Rizatriptan—Myalgia—Fluorouracil—colon cancer	0.00205	0.00205	CcSEcCtD
Rizatriptan—Hyperhidrosis—Vincristine—colon cancer	0.00203	0.00203	CcSEcCtD
Rizatriptan—Epistaxis—Capecitabine—colon cancer	0.00203	0.00203	CcSEcCtD
Rizatriptan—Discomfort—Fluorouracil—colon cancer	0.00202	0.00202	CcSEcCtD
Rizatriptan—Shock—Irinotecan—colon cancer	0.00201	0.00201	CcSEcCtD
Rizatriptan—Nervous system disorder—Irinotecan—colon cancer	0.00201	0.00201	CcSEcCtD
Rizatriptan—Anorexia—Vincristine—colon cancer	0.002	0.002	CcSEcCtD
Rizatriptan—Irritability—Methotrexate—colon cancer	0.00198	0.00198	CcSEcCtD
Rizatriptan—Hyperhidrosis—Irinotecan—colon cancer	0.00198	0.00198	CcSEcCtD
Rizatriptan—Confusional state—Fluorouracil—colon cancer	0.00198	0.00198	CcSEcCtD
Rizatriptan—Bradycardia—Capecitabine—colon cancer	0.00196	0.00196	CcSEcCtD
Rizatriptan—Anaphylactic shock—Fluorouracil—colon cancer	0.00196	0.00196	CcSEcCtD
Rizatriptan—Oedema—Fluorouracil—colon cancer	0.00196	0.00196	CcSEcCtD
Rizatriptan—Anorexia—Irinotecan—colon cancer	0.00195	0.00195	CcSEcCtD
Rizatriptan—Ataxia—Methotrexate—colon cancer	0.00195	0.00195	CcSEcCtD
Rizatriptan—Nervous system disorder—Fluorouracil—colon cancer	0.00192	0.00192	CcSEcCtD
Rizatriptan—Hypoaesthesia—Capecitabine—colon cancer	0.00192	0.00192	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Vincristine—colon cancer	0.00192	0.00192	CcSEcCtD
Rizatriptan—Pharyngitis—Capecitabine—colon cancer	0.00191	0.00191	CcSEcCtD
Rizatriptan—Tachycardia—Fluorouracil—colon cancer	0.00191	0.00191	CcSEcCtD
Rizatriptan—Insomnia—Vincristine—colon cancer	0.0019	0.0019	CcSEcCtD
Rizatriptan—Paraesthesia—Vincristine—colon cancer	0.00189	0.00189	CcSEcCtD
Rizatriptan—Anorexia—Fluorouracil—colon cancer	0.00187	0.00187	CcSEcCtD
Rizatriptan—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.00187	0.00187	CcSEcCtD
Rizatriptan—Insomnia—Irinotecan—colon cancer	0.00185	0.00185	CcSEcCtD
Rizatriptan—Paraesthesia—Irinotecan—colon cancer	0.00184	0.00184	CcSEcCtD
Rizatriptan—Decreased appetite—Vincristine—colon cancer	0.00183	0.00183	CcSEcCtD
Rizatriptan—Dyspnoea—Irinotecan—colon cancer	0.00183	0.00183	CcSEcCtD
Rizatriptan—Somnolence—Irinotecan—colon cancer	0.00182	0.00182	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Vincristine—colon cancer	0.00182	0.00182	CcSEcCtD
Rizatriptan—Fatigue—Vincristine—colon cancer	0.00181	0.00181	CcSEcCtD
Rizatriptan—Dyspepsia—Irinotecan—colon cancer	0.0018	0.0018	CcSEcCtD
Rizatriptan—Tinnitus—Capecitabine—colon cancer	0.0018	0.0018	CcSEcCtD
Rizatriptan—Pain—Vincristine—colon cancer	0.0018	0.0018	CcSEcCtD
Rizatriptan—Constipation—Vincristine—colon cancer	0.0018	0.0018	CcSEcCtD
Rizatriptan—Flushing—Capecitabine—colon cancer	0.00179	0.00179	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00179	0.00179	CcSEcCtD
Rizatriptan—Decreased appetite—Irinotecan—colon cancer	0.00178	0.00178	CcSEcCtD
Rizatriptan—Insomnia—Fluorouracil—colon cancer	0.00177	0.00177	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Irinotecan—colon cancer	0.00177	0.00177	CcSEcCtD
Rizatriptan—Fatigue—Irinotecan—colon cancer	0.00177	0.00177	CcSEcCtD
Rizatriptan—Paraesthesia—Fluorouracil—colon cancer	0.00176	0.00176	CcSEcCtD
Rizatriptan—Constipation—Irinotecan—colon cancer	0.00175	0.00175	CcSEcCtD
Rizatriptan—Pain—Irinotecan—colon cancer	0.00175	0.00175	CcSEcCtD
Rizatriptan—Angiopathy—Capecitabine—colon cancer	0.00175	0.00175	CcSEcCtD
Rizatriptan—Dyspnoea—Fluorouracil—colon cancer	0.00175	0.00175	CcSEcCtD
Rizatriptan—Somnolence—Fluorouracil—colon cancer	0.00174	0.00174	CcSEcCtD
Rizatriptan—Chills—Capecitabine—colon cancer	0.00173	0.00173	CcSEcCtD
Rizatriptan—Dyspepsia—Fluorouracil—colon cancer	0.00173	0.00173	CcSEcCtD
Rizatriptan—Arrhythmia—Capecitabine—colon cancer	0.00172	0.00172	CcSEcCtD
Rizatriptan—Abdominal discomfort—Methotrexate—colon cancer	0.00172	0.00172	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Vincristine—colon cancer	0.00172	0.00172	CcSEcCtD
Rizatriptan—Decreased appetite—Fluorouracil—colon cancer	0.0017	0.0017	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00169	0.00169	CcSEcCtD
Rizatriptan—Mental disorder—Capecitabine—colon cancer	0.00169	0.00169	CcSEcCtD
Rizatriptan—Feeling abnormal—Irinotecan—colon cancer	0.00169	0.00169	CcSEcCtD
Rizatriptan—Erythema—Capecitabine—colon cancer	0.00168	0.00168	CcSEcCtD
Rizatriptan—Dysuria—Methotrexate—colon cancer	0.00168	0.00168	CcSEcCtD
Rizatriptan—Pain—Fluorouracil—colon cancer	0.00168	0.00168	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Irinotecan—colon cancer	0.00167	0.00167	CcSEcCtD
Rizatriptan—Upper respiratory tract infection—Methotrexate—colon cancer	0.00167	0.00167	CcSEcCtD
Rizatriptan—Abdominal pain—Vincristine—colon cancer	0.00166	0.00166	CcSEcCtD
Rizatriptan—Body temperature increased—Vincristine—colon cancer	0.00166	0.00166	CcSEcCtD
Rizatriptan—Flatulence—Capecitabine—colon cancer	0.00165	0.00165	CcSEcCtD
Rizatriptan—Dysgeusia—Capecitabine—colon cancer	0.00164	0.00164	CcSEcCtD
Rizatriptan—Photosensitivity reaction—Methotrexate—colon cancer	0.00164	0.00164	CcSEcCtD
Rizatriptan—Abdominal pain—Irinotecan—colon cancer	0.00162	0.00162	CcSEcCtD
Rizatriptan—Body temperature increased—Irinotecan—colon cancer	0.00162	0.00162	CcSEcCtD
Rizatriptan—Feeling abnormal—Fluorouracil—colon cancer	0.00162	0.00162	CcSEcCtD
Rizatriptan—Muscle spasms—Capecitabine—colon cancer	0.00161	0.00161	CcSEcCtD
Rizatriptan—Vision blurred—Capecitabine—colon cancer	0.00158	0.00158	CcSEcCtD
Rizatriptan—Tremor—Capecitabine—colon cancer	0.00157	0.00157	CcSEcCtD
Rizatriptan—Urticaria—Fluorouracil—colon cancer	0.00156	0.00156	CcSEcCtD
Rizatriptan—Body temperature increased—Fluorouracil—colon cancer	0.00155	0.00155	CcSEcCtD
Rizatriptan—Hypersensitivity—Vincristine—colon cancer	0.00155	0.00155	CcSEcCtD
Rizatriptan—Sweating—Methotrexate—colon cancer	0.00153	0.00153	CcSEcCtD
Rizatriptan—Epistaxis—Methotrexate—colon cancer	0.00151	0.00151	CcSEcCtD
Rizatriptan—Vertigo—Capecitabine—colon cancer	0.00151	0.00151	CcSEcCtD
Rizatriptan—Hypersensitivity—Irinotecan—colon cancer	0.00151	0.00151	CcSEcCtD
Rizatriptan—Asthenia—Vincristine—colon cancer	0.00151	0.00151	CcSEcCtD
Rizatriptan—Syncope—Capecitabine—colon cancer	0.00151	0.00151	CcSEcCtD
Rizatriptan—Palpitations—Capecitabine—colon cancer	0.00148	0.00148	CcSEcCtD
Rizatriptan—Loss of consciousness—Capecitabine—colon cancer	0.00148	0.00148	CcSEcCtD
Rizatriptan—Asthenia—Irinotecan—colon cancer	0.00147	0.00147	CcSEcCtD
Rizatriptan—Cough—Capecitabine—colon cancer	0.00147	0.00147	CcSEcCtD
Rizatriptan—Hypertension—Capecitabine—colon cancer	0.00145	0.00145	CcSEcCtD
Rizatriptan—Hypersensitivity—Fluorouracil—colon cancer	0.00144	0.00144	CcSEcCtD
Rizatriptan—Diarrhoea—Vincristine—colon cancer	0.00144	0.00144	CcSEcCtD
Rizatriptan—Arthralgia—Capecitabine—colon cancer	0.00143	0.00143	CcSEcCtD
Rizatriptan—Chest pain—Capecitabine—colon cancer	0.00143	0.00143	CcSEcCtD
Rizatriptan—Myalgia—Capecitabine—colon cancer	0.00143	0.00143	CcSEcCtD
Rizatriptan—Pharyngitis—Methotrexate—colon cancer	0.00143	0.00143	CcSEcCtD
Rizatriptan—Anxiety—Capecitabine—colon cancer	0.00142	0.00142	CcSEcCtD
Rizatriptan—Discomfort—Capecitabine—colon cancer	0.00141	0.00141	CcSEcCtD
Rizatriptan—Diarrhoea—Irinotecan—colon cancer	0.0014	0.0014	CcSEcCtD
Rizatriptan—Dry mouth—Capecitabine—colon cancer	0.0014	0.0014	CcSEcCtD
Rizatriptan—Dizziness—Vincristine—colon cancer	0.00139	0.00139	CcSEcCtD
Rizatriptan—Pruritus—Fluorouracil—colon cancer	0.00139	0.00139	CcSEcCtD
Rizatriptan—Confusional state—Capecitabine—colon cancer	0.00138	0.00138	CcSEcCtD
Rizatriptan—Oedema—Capecitabine—colon cancer	0.00137	0.00137	CcSEcCtD
Rizatriptan—Dizziness—Irinotecan—colon cancer	0.00135	0.00135	CcSEcCtD
Rizatriptan—Shock—Capecitabine—colon cancer	0.00135	0.00135	CcSEcCtD
Rizatriptan—Nervous system disorder—Capecitabine—colon cancer	0.00134	0.00134	CcSEcCtD
Rizatriptan—Diarrhoea—Fluorouracil—colon cancer	0.00134	0.00134	CcSEcCtD
Rizatriptan—Tinnitus—Methotrexate—colon cancer	0.00134	0.00134	CcSEcCtD
Rizatriptan—Tachycardia—Capecitabine—colon cancer	0.00134	0.00134	CcSEcCtD
Rizatriptan—Vomiting—Vincristine—colon cancer	0.00134	0.00134	CcSEcCtD
Rizatriptan—Rash—Vincristine—colon cancer	0.00133	0.00133	CcSEcCtD
Rizatriptan—Hyperhidrosis—Capecitabine—colon cancer	0.00132	0.00132	CcSEcCtD
Rizatriptan—Dermatitis—Vincristine—colon cancer	0.00132	0.00132	CcSEcCtD
Rizatriptan—Headache—Vincristine—colon cancer	0.00132	0.00132	CcSEcCtD
Rizatriptan—Anorexia—Capecitabine—colon cancer	0.00131	0.00131	CcSEcCtD
Rizatriptan—Angiopathy—Methotrexate—colon cancer	0.0013	0.0013	CcSEcCtD
Rizatriptan—Vomiting—Irinotecan—colon cancer	0.0013	0.0013	CcSEcCtD
Rizatriptan—Dizziness—Fluorouracil—colon cancer	0.0013	0.0013	CcSEcCtD
Rizatriptan—Rash—Irinotecan—colon cancer	0.00129	0.00129	CcSEcCtD
Rizatriptan—Dermatitis—Irinotecan—colon cancer	0.00129	0.00129	CcSEcCtD
Rizatriptan—Chills—Methotrexate—colon cancer	0.00129	0.00129	CcSEcCtD
Rizatriptan—Headache—Irinotecan—colon cancer	0.00128	0.00128	CcSEcCtD
Rizatriptan—Mental disorder—Methotrexate—colon cancer	0.00126	0.00126	CcSEcCtD
Rizatriptan—Erythema—Methotrexate—colon cancer	0.00125	0.00125	CcSEcCtD
Rizatriptan—Nausea—Vincristine—colon cancer	0.00125	0.00125	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00125	0.00125	CcSEcCtD
Rizatriptan—Vomiting—Fluorouracil—colon cancer	0.00125	0.00125	CcSEcCtD
Rizatriptan—Insomnia—Capecitabine—colon cancer	0.00124	0.00124	CcSEcCtD
Rizatriptan—Rash—Fluorouracil—colon cancer	0.00124	0.00124	CcSEcCtD
Rizatriptan—Dermatitis—Fluorouracil—colon cancer	0.00124	0.00124	CcSEcCtD
Rizatriptan—Paraesthesia—Capecitabine—colon cancer	0.00123	0.00123	CcSEcCtD
Rizatriptan—Headache—Fluorouracil—colon cancer	0.00123	0.00123	CcSEcCtD
Rizatriptan—Dysgeusia—Methotrexate—colon cancer	0.00122	0.00122	CcSEcCtD
Rizatriptan—Dyspnoea—Capecitabine—colon cancer	0.00122	0.00122	CcSEcCtD
Rizatriptan—Nausea—Irinotecan—colon cancer	0.00122	0.00122	CcSEcCtD
Rizatriptan—Dyspepsia—Capecitabine—colon cancer	0.00121	0.00121	CcSEcCtD
Rizatriptan—Decreased appetite—Capecitabine—colon cancer	0.00119	0.00119	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Capecitabine—colon cancer	0.00118	0.00118	CcSEcCtD
Rizatriptan—Fatigue—Capecitabine—colon cancer	0.00118	0.00118	CcSEcCtD
Rizatriptan—Vision blurred—Methotrexate—colon cancer	0.00118	0.00118	CcSEcCtD
Rizatriptan—Pain—Capecitabine—colon cancer	0.00117	0.00117	CcSEcCtD
Rizatriptan—Constipation—Capecitabine—colon cancer	0.00117	0.00117	CcSEcCtD
Rizatriptan—Nausea—Fluorouracil—colon cancer	0.00116	0.00116	CcSEcCtD
Rizatriptan—Feeling abnormal—Capecitabine—colon cancer	0.00113	0.00113	CcSEcCtD
Rizatriptan—Vertigo—Methotrexate—colon cancer	0.00112	0.00112	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Capecitabine—colon cancer	0.00112	0.00112	CcSEcCtD
Rizatriptan—Cough—Methotrexate—colon cancer	0.00109	0.00109	CcSEcCtD
Rizatriptan—Urticaria—Capecitabine—colon cancer	0.00109	0.00109	CcSEcCtD
Rizatriptan—Body temperature increased—Capecitabine—colon cancer	0.00108	0.00108	CcSEcCtD
Rizatriptan—Abdominal pain—Capecitabine—colon cancer	0.00108	0.00108	CcSEcCtD
Rizatriptan—Convulsion—Methotrexate—colon cancer	0.00108	0.00108	CcSEcCtD
Rizatriptan—Myalgia—Methotrexate—colon cancer	0.00106	0.00106	CcSEcCtD
Rizatriptan—Arthralgia—Methotrexate—colon cancer	0.00106	0.00106	CcSEcCtD
Rizatriptan—Chest pain—Methotrexate—colon cancer	0.00106	0.00106	CcSEcCtD
Rizatriptan—Discomfort—Methotrexate—colon cancer	0.00105	0.00105	CcSEcCtD
Rizatriptan—Confusional state—Methotrexate—colon cancer	0.00103	0.00103	CcSEcCtD
Rizatriptan—Anaphylactic shock—Methotrexate—colon cancer	0.00102	0.00102	CcSEcCtD
Rizatriptan—Hypersensitivity—Capecitabine—colon cancer	0.00101	0.00101	CcSEcCtD
Rizatriptan—Nervous system disorder—Methotrexate—colon cancer	0.001	0.001	CcSEcCtD
Rizatriptan—Hyperhidrosis—Methotrexate—colon cancer	0.000986	0.000986	CcSEcCtD
Rizatriptan—Asthenia—Capecitabine—colon cancer	0.000983	0.000983	CcSEcCtD
Rizatriptan—Anorexia—Methotrexate—colon cancer	0.000972	0.000972	CcSEcCtD
Rizatriptan—Pruritus—Capecitabine—colon cancer	0.00097	0.00097	CcSEcCtD
Rizatriptan—Diarrhoea—Capecitabine—colon cancer	0.000938	0.000938	CcSEcCtD
Rizatriptan—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000929	0.000929	CcSEcCtD
Rizatriptan—Insomnia—Methotrexate—colon cancer	0.000923	0.000923	CcSEcCtD
Rizatriptan—Paraesthesia—Methotrexate—colon cancer	0.000916	0.000916	CcSEcCtD
Rizatriptan—Dyspnoea—Methotrexate—colon cancer	0.000909	0.000909	CcSEcCtD
Rizatriptan—Somnolence—Methotrexate—colon cancer	0.000907	0.000907	CcSEcCtD
Rizatriptan—Dizziness—Capecitabine—colon cancer	0.000906	0.000906	CcSEcCtD
Rizatriptan—Dyspepsia—Methotrexate—colon cancer	0.000898	0.000898	CcSEcCtD
Rizatriptan—Decreased appetite—Methotrexate—colon cancer	0.000887	0.000887	CcSEcCtD
Rizatriptan—Gastrointestinal disorder—Methotrexate—colon cancer	0.000881	0.000881	CcSEcCtD
Rizatriptan—Fatigue—Methotrexate—colon cancer	0.00088	0.00088	CcSEcCtD
Rizatriptan—Pain—Methotrexate—colon cancer	0.000872	0.000872	CcSEcCtD
Rizatriptan—Vomiting—Capecitabine—colon cancer	0.000871	0.000871	CcSEcCtD
Rizatriptan—Rash—Capecitabine—colon cancer	0.000864	0.000864	CcSEcCtD
Rizatriptan—Dermatitis—Capecitabine—colon cancer	0.000863	0.000863	CcSEcCtD
Rizatriptan—Headache—Capecitabine—colon cancer	0.000858	0.000858	CcSEcCtD
Rizatriptan—Feeling abnormal—Methotrexate—colon cancer	0.000841	0.000841	CcSEcCtD
Rizatriptan—Gastrointestinal pain—Methotrexate—colon cancer	0.000834	0.000834	CcSEcCtD
Rizatriptan—Nausea—Capecitabine—colon cancer	0.000814	0.000814	CcSEcCtD
Rizatriptan—Urticaria—Methotrexate—colon cancer	0.00081	0.00081	CcSEcCtD
Rizatriptan—Abdominal pain—Methotrexate—colon cancer	0.000806	0.000806	CcSEcCtD
Rizatriptan—Body temperature increased—Methotrexate—colon cancer	0.000806	0.000806	CcSEcCtD
Rizatriptan—Hypersensitivity—Methotrexate—colon cancer	0.000752	0.000752	CcSEcCtD
Rizatriptan—Asthenia—Methotrexate—colon cancer	0.000732	0.000732	CcSEcCtD
Rizatriptan—Pruritus—Methotrexate—colon cancer	0.000722	0.000722	CcSEcCtD
Rizatriptan—Diarrhoea—Methotrexate—colon cancer	0.000698	0.000698	CcSEcCtD
Rizatriptan—Dizziness—Methotrexate—colon cancer	0.000675	0.000675	CcSEcCtD
Rizatriptan—Vomiting—Methotrexate—colon cancer	0.000649	0.000649	CcSEcCtD
Rizatriptan—Rash—Methotrexate—colon cancer	0.000643	0.000643	CcSEcCtD
Rizatriptan—Dermatitis—Methotrexate—colon cancer	0.000643	0.000643	CcSEcCtD
Rizatriptan—Headache—Methotrexate—colon cancer	0.000639	0.000639	CcSEcCtD
Rizatriptan—Nausea—Methotrexate—colon cancer	0.000606	0.000606	CcSEcCtD
